Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect

SIMPLE SUMMARY: Developing new therapeutic cancer vaccines is of paramount importance to counteract tumor escape observed after conventional therapies in certain types of cancer. We have previously shown that the combination of two different vaccine platforms, targeting tumor-specific antigens, resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofer, Tamara, Rossi, Matteo, Carboni, Susanna, Di Berardino Besson, Wilma, von Laer, Dorothee, Wollmann, Guido, Derouazi, Madiha, Santiago-Raber, Marie-Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656755/
https://www.ncbi.nlm.nih.gov/pubmed/34885215
http://dx.doi.org/10.3390/cancers13236107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656755/
https://www.ncbi.nlm.nih.gov/pubmed/34885215
http://dx.doi.org/10.3390/cancers13236107

Ejemplares similares